Get alerts of updates about «CeFH lunch seminar: HbA1c in early second trimester and perinatal outcomes»
You have subscribed to alerts about:
- CeFH lunch seminar: HbA1c in early second trimester and perinatal outcomes
Event
CeFH lunch seminar: HbA1c in early second trimester and perinatal outcomes
Presentation by Ellen Øen Carlsen, Centre for Fertility and Health
Presentation by Ellen Øen Carlsen, Centre for Fertility and Health
19. Jun | 2020
This project is part of MoBa eTox, the biobank of MoBa. Blood samples was drawn in week 18 of pregnancy for 2983 women, at the time of ultrasound, and HbA1c levels were measured. The value of measuring HbA1c at this time of pregnancy is not well-established, and currently not recommended as screening for gestational diabetes mellitus. We explored different perinatal outcomes in relation to HbA1c levels, and propose that HbA1c measurement earlier than the current recommended glucose tolerance testing in weeks 24-28 might identify women at risk of adverse outcomes.
The Centre for Fertility and Health is a Centre of Excellence (SFF) at the Norwegian Institute of Public Health funded by the Research Council of Norway.